These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 8135485

  • 1. Suramin and serum insulin-like growth factor levels in metastatic cancer patients.
    Miglietta L, Barreca A, Repetto L, Costantini M, Rosso R, Boccardo F.
    Anticancer Res; 1993; 13(6B):2473-6. PubMed ID: 8135485
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteins.
    Lawrence JB, Conover CA, Haddad TC, Ingle JN, Reid JM, Ames MM, Suman VJ, Marks RS, Erlichman C, Hartmann LC.
    Clin Cancer Res; 1997 Oct; 3(10):1713-20. PubMed ID: 9815555
    [Abstract] [Full Text] [Related]

  • 3. Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men.
    Hong SK, Han BK, Jeong JS, Jeong SJ, Moon KH, Byun SS, Lee SE.
    Asian J Androl; 2008 Mar; 10(2):207-13. PubMed ID: 18097534
    [Abstract] [Full Text] [Related]

  • 4. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
    Unsal E, Köksal D, Yurdakul AS, Atikcan S, Cinaz P.
    Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
    [Abstract] [Full Text] [Related]

  • 5. [Vascular endothelial growth factor and insulin-like-growth factors in prostate cancer. ].
    Trapeznikova MF, Shibaeva AN, Ianshin AA, Urenkov SB, Mironova OS, Kazantseva IA, Kushlinskiĭ NE.
    Urologiia; 2004 May; (1):17-21. PubMed ID: 15022438
    [Abstract] [Full Text] [Related]

  • 6. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
    Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR.
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):721-7. PubMed ID: 12917202
    [Abstract] [Full Text] [Related]

  • 7. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
    Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF, Hsing AW.
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
    [Abstract] [Full Text] [Related]

  • 8. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer.
    Renehan AG, Jones J, Potten CS, Shalet SM, O'Dwyer ST.
    Br J Cancer; 2000 Nov; 83(10):1344-50. PubMed ID: 11044360
    [Abstract] [Full Text] [Related]

  • 9. Insulin-like growth factor (IGF)-I and IGF-II serum concentrations in patients with benign and malignant breast lesions: free IGF-II is correlated with breast cancer size.
    Singer CF, Mogg M, Koestler W, Pacher M, Marton E, Kubista E, Schreiber M.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4003-9. PubMed ID: 15217931
    [Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ, Baxter RC.
    Clin Endocrinol (Oxf); 1997 Mar 15; 46(3):333-42. PubMed ID: 9156044
    [Abstract] [Full Text] [Related]

  • 11. Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
    Oliver SE, Holly J, Peters TJ, Donovan J, Persad R, Gillatt D, Pearce A, Hamdy FC, Neal DE, Gunnell D.
    Urology; 2004 Aug 15; 64(2):317-22. PubMed ID: 15302487
    [Abstract] [Full Text] [Related]

  • 12. Insulin-like growth factor (IGF)-system mRNA quantities in normal and tumor breast tissue of women with sporadic and familial breast cancer risk.
    Voskuil DW, Bosma A, Vrieling A, Rookus MA, van 't Veer LJ.
    Breast Cancer Res Treat; 2004 Apr 15; 84(3):225-33. PubMed ID: 15026620
    [Abstract] [Full Text] [Related]

  • 13. Putative role of serum insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels in the development of prostate cancer in Arab men.
    Kehinde EO, Akanji AO, Mojiminiyi OA, Bashir AA, Daar AS, Varghese R.
    Prostate Cancer Prostatic Dis; 2005 Apr 15; 8(1):84-90. PubMed ID: 15775992
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A, Schally AV, Letsch M, Krupa M, Hebert F, Busto R, Groot K, Varga JL.
    Prostate; 2002 Aug 01; 52(3):173-82. PubMed ID: 12111694
    [Abstract] [Full Text] [Related]

  • 15. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ, Mohan S, Cohen P, Foster BA, Greenberg NM.
    Cancer Res; 1999 May 01; 59(9):2203-9. PubMed ID: 10232609
    [Abstract] [Full Text] [Related]

  • 16. Serum insulin-like growth factor binding protein-3/prostate-specific antigen ratio is a useful predictive marker in patients with advanced prostate cancer.
    Miyata Y, Sakai H, Hayashi T, Kanetake H.
    Prostate; 2003 Feb 01; 54(2):125-32. PubMed ID: 12497585
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factors and breast cancer risk in Chinese women.
    Yu H, Jin F, Shu XO, Li BD, Dai Q, Cheng JR, Berkel HJ, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2002 Aug 01; 11(8):705-12. PubMed ID: 12163322
    [Abstract] [Full Text] [Related]

  • 18. Serum insulin-like growth factor-I levels and prostatic intraepithelial neoplasia: a clue to the relationship between IGF-I physiology and prostate cancer risk.
    Nam RK, Trachtenberg J, Jewett MA, Toi A, Evans A, Emami M, Narod SA, Pollak M.
    Cancer Epidemiol Biomarkers Prev; 2005 May 01; 14(5):1270-3. PubMed ID: 15894684
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factors I and II peptide and messenger RNA levels in macrosomic infants of diabetic pregnancies.
    Roth S, Abernathy MP, Lee WH, Pratt L, Denne S, Golichowski A, Pescovitz OH.
    J Soc Gynecol Investig; 1996 May 01; 3(2):78-84. PubMed ID: 8796812
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB, Hansen TB, Frystyk J, Ladefoged SD, Pedersen FB, Christiansen JS.
    Clin Nephrol; 1999 Aug 01; 52(2):103-9. PubMed ID: 10480221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.